Product logins

Find logins to all Clarivate products below.


Axial Spondyloarthritis – Epidemiology – Extrapolated Worldwide Coverage

Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key AxSpA patient populations covering 171 countries and more than 99% of the global population, delivered in an interactive dashboard-style download.

Use the Extrapolated Worldwide Coverage dashboard to do the following:

  • View 10-year forecasts of the total prevalent cases of AxSpA for all 171 countries, stratified by region and World Bank income status.
  • Aggregate country-level estimates into regional estimates, according to user preference or as required by regulators for orphan drug designations.
  • Visualize global correlations between disease risk or patient population size and key indicators of market opportunity such as GDP per capita and healthcare spend per capita.
  • Generate and export global heat maps of disease risk or patient population size.

The Extrapolated Worldwide Coverage dashboard is available as an Excel file in the “Downloads” section. It is available for purchase by clients who subscribe to all 45 countries covered by Clarivate Epidemiology. For subscription and entitlement queries, please contact Clarivate.support@clarivate.com.

Related Market Assessment Reports

Report
Psoriatic Arthritis – Landscape & Forecast – Disease Landscape & Forecast (G7)
The psoriatic arthritis (PsA) treatment market is experiencing significant shifts with the introduction of newer targeted therapies, such as AbbVie’s Rinvoq and Skyrizi, and UCB’s bimekizumab…
Report
Axial Spondyloarthritis – Unmet Need – Unmet Need – Ankylosing Spondylitis (US/EU)
Over the past two decades, TNF-α inhibitors (AbbVie’s Humira, Amgen / Pfizer’s Enbrel, Johnson & Johnson Innovative Medicine’s Remicade and Simponi, and UCB’s Cimzia) have significantly…
Report
Endometrial Cancer – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of endometrial cancer comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence of…
Report
Pemphigus Vulgaris – Epidemiology – Epidemiology Dashboard
Clarivate Epidemiology’s coverage of pemphigus vulgaris comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the diagnosed prevalence and the…
Report
Pemphigus Vulgaris – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of pemphigus vulgaris (PV) comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States, France…